0135 GMT - Singapore Exchange's ongoing product offerings' enhancements can help boost its valuation multiples, OCBC Investment Research's Research team say in a note. SGX elaborated on how it plans to achieve 6%-8% CAGR revenue growth on medium-term basis, the team says. Initiatives include driving an upward trajectory in over-the-counter FX and derivatives, with OTC FX expected to contribute a mid- to high-single-digit percentage contribution to Ebitda, the team says. Strengthening its platforms is another growth area to enhance operational efficiencies via use of technology and data analytics. OCBC raises the stock's fair value estimate to S$16.15 from S$14.78 with an unchanged hold rating. Shares are 0.4% lower at S$15.88. (ronnie.harui@wsj.com)
(END) Dow Jones Newswires
August 11, 2025 21:35 ET (01:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.